Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends selling Tata Motors, Tata Steel, Aurobindo Pharma and Adani Ports and advises buying Hero MotoCorp.
Prakash Gaba of prakashgaba.com is of the view that Force Motors can climb to Rs 4950 while Axis Bank can slip to Rs 480.
Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma and Snowman Logistics.
Vishal Malkan of malkansview.com recommends selling Voltas with a target of Rs 375 and Jet Airways with a target of Rs 460.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy IGL and Aurobindo Pharma and sell Mindtree.
Here are analysts' views on 11 stocks. Citi says Aurobindo Pharma remains India's top pharma pick as Teva business passes by and key overhang is lifted. It expects focus to shift back to company's robust fundamentals.
Mayuresh Joshi of Angel Broking advises holding Aurobindo Pharma.
Dhananjay Sinha of Emkay Global Financial Services in an interview with CNBC-TV18 spoke about stocks and sectors.
According to Dipan Mehta, Member at BSE & NSE, Aurobindo Pharma is a top pick.
Mitesh Thacker of miteshthacker.com advises buying Aurobindo Pharma and Dewan Housing Finance Corporation.
Sudarshan Sukhani of s2analytics.com advises buying Yes Bank, Aurobindo Pharma and Bharat Forge.
In an interview to CNBC-TV18's Latha Venkatesh and Anuj Singhal, SP Tulsian of sptulsian.com shared his readings and outlook on specific stocks and sectors.
Here are a few stocks picked up by CNBC-TV18's analysts to focus today - stocks expected to gain are IGL, Vivimed Labs, Balaji Telefilms, ARSS infra, Motherson Sumi, Aurobindo Pharma, MPhasis and Tata Global Beverages while stocks expected to be under pressure are REC, Manpasand Beverages, Ahluwalia Contracts and Bajaj Finserv.
Kunal Saraogi of Equityrush advises selling IDBI with a target of Rs 68.
According to Ashwani Gujral of ashwanigujral.com, one may buy Aurobindo Pharma and advises selling ICICI Bank and Engineers India.
In an interview to CNBC-TV18, Prakash Diwan of Altamount Capital Management shared his readings and outlook on specific stocks and sectors.
SP Tulsian of sptulsian.com says Bharat Forge is a good stock if one has a medium-term view of 12-18 months but for those with short-term timeframe can book profits.
I am taking this as a second round of up move on anticipation of very good numbers to be seen from all of them and more specially if you need to put me in the pecking order probably I will go with Ujjivan, Capital First and then the Equitas Holding, said SP Tulsian.
Ashish Chaturmohta of Sanctum Wealth Management recommends buying TVS Motor, Arvind and Aurobindo Pharma.
Rajat Bose of rajatkbose.com is of the view that one can prefer pharma stocks.
Rajat Bose of rajatkbose.com recommends selling Yes Bank and feels that one can carry forward Aurobindo Pharma as the stock may test Rs 867.
Sandeep Wagle of powermywealth.com recommends buying Aurobindo Pharma and TVS Motor and sell Dabur India.
Prakash Gaba of prakashgaba.com like Aurobindo Pharma and feels that BPCL is an indicator buy.
Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma and HDFC.
Sudarshan Sukhani of s2analytics.com recommends buying Asian Paints, Zee Entertainment and Lupin and advises selling BEML and CESC.